0001209191-18-035591.txt : 20180605
0001209191-18-035591.hdr.sgml : 20180605
20180605160655
ACCESSION NUMBER: 0001209191-18-035591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180601
FILED AS OF DATE: 20180605
DATE AS OF CHANGE: 20180605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FITZGERALD EDWARD M
CENTRAL INDEX KEY: 0001242993
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 18881171
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 CAMBRIDGE PARKWAY
STREET 2: SUITE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 760-603-2732
MAIL ADDRESS:
STREET 1: 2855 GAZELLE CT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-01
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001242993
FITZGERALD EDWARD M
C/O AKCEA THERAPEUTICS, INC.
55 CAMBRIDGE PARKWAY
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (right to buy)
23.46
2018-06-01
4
A
0
26400
0.00
A
2028-05-31
Common Stock
26400
26400
D
The shares vest over a four year period in equal annual installments beginning on June 1, 2018.
/s/ Jeffrey Goldberg, Attorney-in-Fact
2018-06-01